Using fractional exhaled nitric oxide (FeNO) to diagnose steroid‐responsive disease and guide asthma management in routine care

In the UK, FeNO is being used in primary practice to guide ICS initiation and dosing decisions and to identify poor ICS adherence. Simple algorithms to guide clinicians in the practical use of FeNO could improved diagnostic accuracy and better tailored asthma regimens.